Sunrun Inc (RUN)
Return on equity (ROE)
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | -3,174,592 | -711,056 | -1,368,328 | -1,451,928 | -1,699,883 | -1,286,738 | -6,718 | -271,948 | -92,644 | -194,184 | -380,615 | -212,103 | -79,423 | -210,224 | -196,906 | -169,224 | -173,394 | 8,426 | -31 | 12,238 |
Total stockholders’ equity | US$ in thousands | 2,554,210 | 5,278,030 | 5,365,740 | 5,180,450 | 5,230,230 | 5,611,110 | 6,597,450 | 6,467,760 | 6,708,120 | 6,618,500 | 6,346,680 | 6,264,340 | 6,254,740 | 6,223,110 | 6,156,460 | 6,165,560 | 6,077,910 | 1,033,540 | 888,167 | 872,473 |
ROE | -124.29% | -13.47% | -25.50% | -28.03% | -32.50% | -22.93% | -0.10% | -4.20% | -1.38% | -2.93% | -6.00% | -3.39% | -1.27% | -3.38% | -3.20% | -2.74% | -2.85% | 0.82% | -0.00% | 1.40% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-3,174,592K ÷ $2,554,210K
= -124.29%
Sunrun Inc's return on equity (ROE) has exhibited significant fluctuations over the periods reported. The ROE started at a modest 1.40% as of March 31, 2020, turned negative in the subsequent quarter, and continued to decline reaching a low of -124.29% by December 31, 2024.
The negative ROE values indicate that the company's net income is insufficient to cover shareholder's equity, suggesting potential financial difficulties. It is important to note that a negative ROE can result from net losses or high levels of debt relative to equity.
Sunrun Inc may need to closely evaluate its financial performance and capital structure to address the declining trend in ROE and work towards improving profitability and shareholder value. Furthermore, investors and stakeholders should exercise caution and conduct a thorough analysis of the company's financial health and strategic initiatives.
Peer comparison
Dec 31, 2024